Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 2
2006 1
2011 2
2012 1
2013 3
2014 3
2015 4
2016 1
2017 3
2018 2
2019 1
2020 1
2021 4
2022 7
2023 7
2024 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
Hybrid Closed-Loop Therapy in Adults With Type 1 Diabetes and Above-Target HbA1c: A Real-world Observational Study.
Crabtree TSJ, Griffin TP, Yap YW, Narendran P, Gallen G, Furlong N, Cranston I, Chakera A, Philbey C, Karamat MA, Saraf S, Kamaruddin S, Gurnell E, Chapman A, Hussain S, Elliott J, Leelarathna L, Ryder REJ, Hammond P, Lumb A, Choudhary P, Wilmot EG; ABCD Closed-Loop Audit Contributors. Crabtree TSJ, et al. Among authors: ryder rej. Diabetes Care. 2023 Oct 1;46(10):1831-1838. doi: 10.2337/dc23-0635. Diabetes Care. 2023. PMID: 37566697 Free PMC article.
Cardioprotective Effects of Pioglitazone in Type 2 Diabetes.
Tripathy D, Solis-Herrera C, Ryder REJ. Tripathy D, et al. Among authors: ryder rej. Diabetes Spectr. 2021 Aug;34(3):243-247. doi: 10.2337/ds20-0078. Epub 2021 Aug 18. Diabetes Spectr. 2021. PMID: 34511850 Free PMC article.
A UK nationwide study of adults admitted to hospital with diabetic ketoacidosis or hyperosmolar hyperglycaemic state and COVID-19.
Field BCT, Ruan Y, Várnai KA, Davies J, Ryder REJ, Gandhi R, Harris S, Nagi D, Patel D, Kempegowda P, Wild SH, Wilmot EG, Khunti K, Rea R, Narendran P; ABCD COVID-19 Audit Group. Field BCT, et al. Among authors: ryder rej. Diabetes Obes Metab. 2023 Jul;25(7):2012-2022. doi: 10.1111/dom.15076. Epub 2023 Apr 25. Diabetes Obes Metab. 2023. PMID: 37016487
Real-world diabetes prevention: from theory to practice.
Ryder REJ. Ryder REJ. Lancet Diabetes Endocrinol. 2018 Oct;6(10):756-757. doi: 10.1016/S2213-8587(18)30267-5. Epub 2018 Sep 14. Lancet Diabetes Endocrinol. 2018. PMID: 30224285 No abstract available.
Endoscopic Duodenal-Jejunal Bypass Liner Treatment for Type 2 Diabetes and Obesity: Glycemic and Cardiovascular Disease Risk Factor Improvements in 1,022 Patients Treated Worldwide.
Ryder REJ, Laubner K, Benes M, Haluzik M, Munro L, Frydenberg H, Teare JP, Ruban A, Fishman S, Santo E, Stengel R, De Jonge C, Greve JW, Cohen RV, Aboud CM, Holtmann GJ, Rich G, McMaster JJ, Battelino T, Kotnik P, Byrne JP, Mason JC, Bessell J, Bascomb J, Kow L, Collins J, Chisholm J, Pferschy PN, Sourij H, Cull ML, Wyres MC, Drummond R, McGowan B, Amiel SA, Yadagiri M, Sen Gupta P, Aberle J, Seufert J. Ryder REJ, et al. Diabetes Care. 2023 Apr 1;46(4):e89-e91. doi: 10.2337/dc22-1952. Diabetes Care. 2023. PMID: 36716004 Free PMC article. No abstract available.
Duodenal-jejunal bypass liner for the treatment of type 2 diabetes and obesity: 3-year outcomes in the First National Health Service (NHS) EndoBarrier Service.
Ryder REJ, Yadagiri M, Burbridge W, Irwin SP, Gandhi H, Bashir T, Allden RA, Wyres M, Cull M, Bleasdale JP, Fogden EN, Anderson MR, Sen Gupta P. Ryder REJ, et al. Diabet Med. 2022 Jul;39(7):e14827. doi: 10.1111/dme.14827. Epub 2022 Mar 29. Diabet Med. 2022. PMID: 35285080 Free PMC article. No abstract available.
44 results